Newsroom
Category
May 19, 2026
Scientists at The University of Texas at San Antonio (UT San Antonio) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.
May 5, 2026
From the moment of diagnosis, UT Health San Antonio patients are connected to a system designed to expand their treatment possibilities and bring the full strength of medicine and research to their care. Specialized programs focus on common and rare cancers, which allows for more personalized treatment approaches. For those at increased risk, services such as cancer genetics counseling and risk-reduction clinics offer early insight and prevention strategies.
April 23, 2026
Written by: Claire Kowalick More than 70% of cancers — including breast, bladder, cervical and lung cancer — show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. “APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do […]
April 13, 2026
For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at The University of Texas at San Antonio (UT San Antonio) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, […]
March 31, 2026
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Susan Anasagasti SAN ANTONIO, March 31, 2026 — The San Antonio Breast Cancer Symposium® drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio. Held each December at the Henry B. […]
March 24, 2026
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.
